Lutein & Zeaxanthin and Lutein & Zeaxanthin for AMD progression (at-risk)
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Compound or practice
Lutein & Zeaxanthin
Eye-protective carotenoids with real evidence for slowing age-related macular degeneration.
Grade B2 graded outcomesrevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Evidence brief
Lutein & Zeaxanthin for AMD progression (at-risk)
Evidence grade B — AREDS2
Grade B1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | Lutein & Zeaxanthin | Lutein & Zeaxanthin for AMD progression (at-risk) |
|---|---|---|
| AMD progression (at-risk) | Evidence grade BModerate effecthighAREDS2 | Evidence grade BModerate effecthighAREDS2 |
Graded only in Lutein & Zeaxanthin
- Visual performance / glare Small effectEvidence grade C
Graded only in Lutein & Zeaxanthin for AMD progression (at-risk)
None — every outcome it grades is graded in both.
Conditions
Only in Lutein & Zeaxanthin
- Age-related macular degeneration May improveEvidence grade B
Only in Lutein & Zeaxanthin for AMD progression (at-risk)
None.
What each entry says about the other
- Lutein & Zeaxanthin for AMD progression (at-risk)’s entry · Goes with: Read the full Lutein & Zeaxanthin monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.